Guangzhou Sinogen Pharmaceutical Co., Ltd
2 clinical trials · Sponsor
◉ Watch Guangzhou Sinogen Pharmaceutical Co., Ltd
| Record | Firm | Date |
|---|---|---|
| Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor (NCT05103345) | Guangzhou Sinogen Pharmaceutical Co., Ltd | 2023-04-19 |
| Study of SGN1 in Patients With Advanced Solid Tumor (NCT05038150) | Guangzhou Sinogen Pharmaceutical Co., Ltd | 2023-01-16 |
Track Guangzhou Sinogen Pharmaceutical Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.